Childhood Racial Segregation in School Tied to Late-Life Cognitive Outcomes
By Lori Solomon HealthDay Reporter
TUESDAY, Jan. 7, 2025 -- Childhood exposure to school segregation is associated with worse late-life cognitive outcomes among older Black adults, according to a study published online Jan. 3 in JAMA Network Open.
Zhuoer Lin, Ph.D., from University of Illinois Chicago, and colleagues investigated the association between childhood contextual exposure to school racial segregation and cognitive outcomes in later life. The analysis included data from older U.S. adults participating in the Health and Retirement Study (3,566 Black and 17,555 White participants).
The researchers found that participants exposed to high versus low segregation showed lower cognitive scores (13.6 versus 14.5) and a higher prevalence of cognitive impairment (37.0 versus 28.0 percent) and dementia (14.1 versus 9.3 percent). There was a significant negative association between school segregation and later-life cognitive outcomes among Black participants, but not among White participants, in an adjusted analysis. Across the life course, potential mediators included educational attainment (57.6 to 72.6 percent of the association), yet the findings were significant among Black participants for all outcomes. When accounting for all mediators and covariates, Black participants exposed to high segregation showed significantly lower cognitive scores (coefficient, −0.26) and a higher likelihood of cognitive impairment (adjusted odds ratio, 1.35) and dementia (adjusted odds ratio, 1.26).
"These findings suggest that strengthened efforts to reduce school racial segregation could have lasting benefits for cognitive health and advance racial equity, particularly given the enduring segregation of schools as a prominent form of structural racism in the United States," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-01-08 06:00
Read more
- Astellas Doses First Patient in Phase 3 Study of Setidegrasib (ASP3082) for KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
- Removing Universal Hep B Shot Likely to Increase Neonatal Infections
- Phase III Study Results with Bayer’s FXIa Inhibitor Asundexian Demonstrating Substantial Reduction in Ischemic Stroke with No Increase in ISTH Major Bleeding Versus Placebo Published in New England Journal of Medicine
- NIH-Funded Study Suggests That Testosterone Suppresses Brain Tumor Growth in Males
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA Approves Inqovi in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions